127 related articles for article (PubMed ID: 38224014)
21. Targeted blocking of CCR2 and CXCR2 improves the efficacy of transarterial chemoembolization of hepatocarcinoma.
Tian Z; Hou X; Liu W; Shao C; Gao L; Jiang J; Zhang L; Han Z; Wei L
Cancer Cell Int; 2022 Nov; 22(1):362. PubMed ID: 36403057
[TBL] [Abstract][Full Text] [Related]
22. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils.
Pan JJ; Xie SZ; Zheng X; Xu JF; Xu H; Yin RQ; Luo YL; Shen L; Chen ZR; Chen YR; Yu SZ; Lu L; Zhu WW; Lu M; Qin LX
Cancer Lett; 2024 Jun; 592():216903. PubMed ID: 38670307
[TBL] [Abstract][Full Text] [Related]
23. IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.
Wu L; Awaji M; Saxena S; Varney ML; Sharma B; Singh RK
Am J Pathol; 2020 Jan; 190(1):222-233. PubMed ID: 31654638
[TBL] [Abstract][Full Text] [Related]
24. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gαi-2 and Gαq/11.
Chen MC; Baskaran R; Lee NH; Hsu HH; Ho TJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
J Cell Physiol; 2019 Jul; 234(7):11822-11834. PubMed ID: 30552676
[TBL] [Abstract][Full Text] [Related]
25. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways.
Cui D; Zhao Y; Xu J
Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567
[TBL] [Abstract][Full Text] [Related]
26. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
Kasashima H; Yashiro M; Nakamae H; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
PLoS One; 2017; 12(6):e0178635. PubMed ID: 28575019
[TBL] [Abstract][Full Text] [Related]
28. DIF-1 exhibits anticancer activity in breast cancer via inhibition of CXCLs/CXCR2 axis-mediated communication between cancer-associated fibroblasts and cancer cells.
Seto-Tetsuo F; Arioka M; Miura K; Inoue T; Igawa K; Tomooka K; Sasaguri T
Int Immunopharmacol; 2023 Apr; 117():109913. PubMed ID: 36812674
[TBL] [Abstract][Full Text] [Related]
29. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
Front Immunol; 2021; 12():667177. PubMed ID: 34025668
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
Park GY; Pathak HB; Godwin AK; Kwon Y
Cell Oncol (Dordr); 2021 Feb; 44(1):77-92. PubMed ID: 32910411
[TBL] [Abstract][Full Text] [Related]
31. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
32. Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis.
Zhang F; Mulvaney O; Salcedo E; Manna S; Zhu JZ; Wang T; Ahn C; Pop LM; Hannan R
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067390
[TBL] [Abstract][Full Text] [Related]
33. Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice.
Shang K; Bai YP; Wang C; Wang Z; Gu HY; Du X; Zhou XY; Zheng CL; Chi YY; Mukaida N; Li YY
PLoS One; 2012; 7(12):e51848. PubMed ID: 23272179
[TBL] [Abstract][Full Text] [Related]
34. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
[TBL] [Abstract][Full Text] [Related]
35. Cell-specific regulatory effects of CXCR2 on cholestatic liver injury.
Konishi T; Schuster RM; Goetzman HS; Caldwell CC; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G773-G783. PubMed ID: 31604030
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model.
Jacobs JP; Ortiz-Lopez A; Campbell JJ; Gerard CJ; Mathis D; Benoist C
Arthritis Rheum; 2010 Jul; 62(7):1921-32. PubMed ID: 20506316
[TBL] [Abstract][Full Text] [Related]
37. A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.
Vieira SM; Lemos HP; Grespan R; Napimoga MH; Dal-Secco D; Freitas A; Cunha TM; Verri WA; Souza-Junior DA; Jamur MC; Fernandes KS; Oliver C; Silva JS; Teixeira MM; Cunha FQ
Br J Pharmacol; 2009 Oct; 158(3):779-89. PubMed ID: 19702783
[TBL] [Abstract][Full Text] [Related]
38. CXCR2 is critical to hyperoxia-induced lung injury.
Sue RD; Belperio JA; Burdick MD; Murray LA; Xue YY; Dy MC; Kwon JJ; Keane MP; Strieter RM
J Immunol; 2004 Mar; 172(6):3860-8. PubMed ID: 15004193
[TBL] [Abstract][Full Text] [Related]
39. Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.
Zhang Z; Cherryholmes G; Chang F; Rose DM; Schraufstatter I; Shively JE
Eur J Immunol; 2009 Nov; 39(11):3181-94. PubMed ID: 19750480
[TBL] [Abstract][Full Text] [Related]
40. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.
Zhang W; Wang H; Sun M; Deng X; Wu X; Ma Y; Li M; Shuoa SM; You Q; Miao L
Cancer Commun (Lond); 2020 Mar; 40(2-3):69-80. PubMed ID: 32237072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
